We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Chemotherapy Response Linked to Two Genes

By Biotechdaily staff writers
Posted on 23 Jun 2004
Cancer researchers have shown that genetic variation in two genes that code for DNA repair enzymes are linked to the survival time of patients receiving platinum-based chemotherapy for nonsmall cell lung cancer (NSCLC).

Investigators at Massachusetts General Hospital (Boston, USA) used polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) to evaluate genetic polymorphisms of the XPD (Asp312Asn) and XRCC1 (Arg399Gln) DNA repair genes in 103 patients with stage III (54%) and IV (46%) NSCLC treated with platinum-based chemotherapy.

They reported in the June 1, 2004, online edition of the Journal of Clinical Oncology that while patients with no variations survived a median of 20.4 months, those with a total of three variations in the XPD and XRCC1 genes survived a median of 6.8 months. More...
Patients with one variation survived 16.6 months, while those with two variations survived a median of 11 months.

The number of genetic variations present independently predicted length of survival irrespective of the patients' ability to carry out daily activities, their stage of disease, or the type of chemotherapy they received.
"The concept of selecting a chemotherapy drug based on a patient's genetic make-up is relatively new and very exciting,” said first author Dr. Sarada Gurubhagavatula, a physician at Massachusetts General Hospital. "We hope that this type of research will one day enable doctors and patients to make more informed decisions about chemotherapy treatments.”




Related Links:
Massachusetts General Hospital

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Simple Whole-Blood Screen Identifies Elevated Bile Acids Linked to Liver Disease

Liver disease can progress silently until treatment options become more limited. Routine blood panels measure markers such as cholesterol, bilirubin, and triglycerides but typically do not include bile... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.